• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Clorox Company

    6/25/26 4:16:17 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary
    Get the next $CLX alert in real time by email
    false 0000021076 http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanEmployerCommonStockMember 0000021076 2025-01-01 2025-12-31 0000021076 CLX:EBP007Member 2025-12-31 0000021076 CLX:EBP007Member 2024-12-31 0000021076 CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 CLX:EBP007Member CLX:NoParticipantsMember 2025-01-01 2025-12-31 0000021076 CLX:EBP007Member CLX:LimitedParticipantMember 2007-01-01 2012-12-31 0000021076 CLX:EBP007Member CLX:NoLimitParticipantMember 2007-01-01 2007-01-31 0000021076 CLX:EBP007Member CLX:NonElectiveEmployerContributionMember 2025-01-01 2025-12-31 0000021076 srt:MinimumMember CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 srt:MaximumMember CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 CLX:EBP007Member 2024-01-01 2024-12-31 0000021076 us-gaap:ShareBasedCompensationAwardTrancheOneMember CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 us-gaap:ShareBasedCompensationAwardTrancheTwoMember CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 us-gaap:ShareBasedCompensationAwardTrancheThreeMember CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 CLX:ShareBasedCompensationAwardTrancheFourMember CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 CLX:ShareBasedCompensationAwardTrancheFiveMember CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel2Member us-gaap:MutualFundMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:MutualFundMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel1Member us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel2Member us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel1Member CLX:InvestmentExcludingCommonCollectiveTrustMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel2Member CLX:InvestmentExcludingCommonCollectiveTrustMember 2025-12-31 0000021076 CLX:EBP007Member CLX:InvestmentExcludingCommonCollectiveTrustMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember 2025-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel2Member us-gaap:MutualFundMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:MutualFundMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:CommonStockMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel1Member CLX:InvestmentExcludingCommonCollectiveTrustMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:FairValueInputsLevel2Member CLX:InvestmentExcludingCommonCollectiveTrustMember 2024-12-31 0000021076 CLX:EBP007Member CLX:InvestmentExcludingCommonCollectiveTrustMember 2024-12-31 0000021076 CLX:EBP007Member us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember 2024-12-31 0000021076 Vanguard Total International Stock Market Index Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Total International Stock Market Index Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Eaton Vance Atlanta Capital SMID Cap Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Eaton Vance Atlanta Capital SMID Cap Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Northern World Selection Index Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Northern World Selection Index Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2025 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2025 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2030 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2030 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2035 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2035 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2040 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2040 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2045 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2045 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2050 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2050 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2055 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2055 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2060 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2060 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2065 Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement 2065 Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement Inc Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Target Retirement Inc Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Mutual fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Institutional 500 Index Trust [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Institutional 500 Index Trust [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Vanguard Institutional Total Bond Market Index Trust [Member] CLX:EBP007Member 2025-12-31 0000021076 Vanguard Institutional Total Bond Market Index Trust [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 State Street Small Mid Cap Trust [Member] CLX:EBP007Member 2025-12-31 0000021076 State Street Small Mid Cap Trust [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 J.P. Morgan Chase Bank US Active Core Equity Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 J.P. Morgan Chase Bank US Active Core Equity Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Galliard Stable Return Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Galliard Stable Return Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 MFS International Equity Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 MFS International Equity Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Prudential Global Invesment Management Core Plus Bond Fund [Member] CLX:EBP007Member 2025-12-31 0000021076 Prudential Global Invesment Management Core Plus Bond Fund [Member] CLX:EBP007Member 2025-01-01 2025-12-31 0000021076 Common collective trust fund [Member] CLX:EBP007Member 2025-12-31 0000021076 The Clorox Company Common Stock [Member] CLX:EBP007Member 2025-12-31 0000021076 The Clorox Company Common Stock [Member] CLX:EBP007Member 2025-01-01 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    ____________________

     

    FORM 11-K

     

    FOR ANNUAL REPORTS OF EMPLOYEE STOCK

    PURCHASE, SAVINGS AND SIMILAR PLANS

    PURSUANT TO SECTION 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    (Mark One):

     

    ☑  ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the fiscal year ended December 31, 2025

     

    OR

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from ___________________ to ____________________

     

    Commission file number 1-07151

     

    A. Full title of the plan and the address of the plan, if different from that of the issuer named below:

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

     

    B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

     

    The Clorox Company

    1221 Broadway

    Oakland, CA 94612-1888

     

     

     

    Report of Independent Registered Public Accounting Firm
    Financial Statements and Supplemental Information

     

    The Clorox Company Employee Retirement Investment Plan for Puerto Rico

     

    As of December 31, 2025 and 2024 and for the
    Plan year ended December 31, 2025

     

     

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

     

    Financial Statements and Supplemental Information

     

    As of December 31, 2025 and 2024

    and for the Plan Year ended December 31, 2025

     

    Contents

     

    Report of Independent Registered Public Accounting Firm 1
       
    Audited Financial Statements  
       
    Statements of Net Assets Available for Benefits 3
    Statement of Changes in Net Assets Available for Benefits 4
    Notes to Financial Statements 5
       
    Supplemental Information  
       
    Schedule H, Line 4i – Schedule of Assets (Held at End of Year) 13
       
    Exhibit 23.1 – Consent of Independent Registered Public Accounting Firm 14

     

     

     

    Report of Independent Registered Public Accounting Firm

     

    To the Participants and Employee Benefits Committee of

    The Clorox Company Employee

    Retirement Investment Plan for Puerto Rico

     

    Opinion on the Financial Statements

     

    We have audited the accompanying statements of net assets available for benefits of The Clorox Company Employee Retirement Investment Plan for Puerto Rico (the Plan) as of December 31, 2025 and 2024, the related statement of changes in net assets available for benefits for the year ended December 31, 2025, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2025 and 2024, and the changes in net assets available for benefits for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

     

    Basis for Opinion

     

    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

     

    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

     

    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

     

    1

     

    Opinion on the Supplemental Information

     

    The supplemental information included in Schedule H, Line 4(i) – Schedule of Assets (Held at End of Year) as of December 31, 2025, has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information in the accompanying schedule, we evaluated whether the supplemental information, including its form and content, is presented in conformity with Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information in the accompanying schedule is fairly stated, in all material respects, in relation to the financial statements as a whole.

     

    /s/ Baker Tilly US, LLP

     

    Seattle, Washington

    June 25, 2026

     

    We have served as the Plan’s auditor since 2013.

     

    2

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

    Statements of Net Assets Available for Benefits

    As of December 31, 2025 and 2024

               
       December 31, 
       2025   2024 
             
    Assets          
    Investments, at fair value  $22,190,794   $20,694,177 
    Receivables:          
    Notes receivable from participants   499,367    446,374 
    Employers’ contributions   211,501    241,264 
    Total receivables   710,868    687,638 
    Net assets available for benefits  $22,901,662   $21,381,815 

     

    See accompanying notes to the financial statements

     

    3

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

    Statement of Changes in Net Assets Available for Benefits

    For the Plan Year ended December 31, 2025

     

          
    Additions to (deductions from) net assets attributed to:     
    Investment and other income:     
    Interest income and dividends  $465,969 
    Net appreciation in fair value of investments   2,473,113 
    Total investment and other income   2,939,082 
          
    Contributions:     
    Participants   379,196 
    Employers   337,325 
    Total contributions   716,521 
          
    Benefits paid to participants   (2,111,295)
    Administrative expenses   (24,461)
    Total benefits paid and administrative expenses   (2,135,756)
          
    Net increase   1,519,847 
          
    Net assets available for benefits:     
    Beginning of year   21,381,815 
    End of year  $22,901,662 

     

    See accompanying notes to the financial statements

     

    4

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

     

    Notes to Financial Statements

     

    December 31, 2025

     

    1. Description of the Plan

     

    The following description of The Clorox Company Employee Retirement Investment Plan for Puerto Rico (“the Plan”) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

     

    General

     

    The Plan is a defined contribution plan covering most salaried and hourly production employees of Clorox Manufacturing Company of Puerto Rico, Inc. (the “Company”) (previously, The Clorox Company of Puerto Rico) and those affiliates of the Company that adopt the Plan for the benefit of their Puerto Rico resident employees (the “Companies”), except for (i) leased employees and (ii) non-resident aliens with no Puerto Rico source of income, unless such coverage is specified in the written agreement. Participants are eligible to participate on the first day of employment following completion of one hour of service with the Companies. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). The Employee Benefits Committee (the “Committee”) administers the Plan. Banco Popular de Puerto Rico serves as the Plan’s trustee. Vanguard Group, Inc. (“Vanguard”) serves as the Plan’s record-keeper and custodian.

     

    The Companies maintain a non-leveraged employee stock ownership plan (the “ESOP”). The ESOP is maintained as part of the Plan and is designed to invest primarily in the Company’s common stock. If elected, the participants can choose to (i) reinvest the dividends or (ii) receive the dividends in cash. No participant shall be permitted to direct more than 5% of the contributions to be made to the Plan on his or her behalf in the ESOP fund; and no participant shall be permitted to effect a transfer or exchange from another investment fund into the ESOP fund if the portion of the participant’s account invested in the ESOP fund would exceed 5% of his or her account balance immediately after such transfer or exchange. From January 1, 2007 up to December 31, 2012 the limit was 10%. Prior to January 1, 2007 no limit was implemented; as such, there are certain participants whose investment in the ESOP fund exceeds 10% of their total account balance.

     

    Contributions

     

    Participants may contribute up to 20% of their covered compensation, up to 10% on a pre-tax and after-tax basis, respectively, as defined in the Plan. Generally, covered/eligible compensation consists of regular pay plus most bonuses, overtime and vacation pay.

     

    5

     

    Pre-tax contributions are subject to a $15,000 limit specified under the Puerto Rico Internal Revenue Code of 2011, as amended, (the “Code”).

     

    Newly eligible participants who do not make a salary deferral contribution election, or fail to elect to decline a deferral contribution, are automatically enrolled in the Plan at a 6% contribution rate.

     

    Employees receive a dollar for dollar employer matching contribution up to a maximum of 4% of eligible compensation. Participants need to have completed 1one year of service to receive the match. Matching contributions are funded each pay period.

     

    Eligible participants also receive a non-elective employer contribution.  Participants must have completed one year of service and be an active employee at the end of the Plan year to be able to receive the non-elective employer contribution. The non-elective employer contribution is equal to 6% of eligible compensation during the plan year. The non-elective employer contribution is funded during the quarter subsequent to the Plan year end. See “Vesting” section for more information.

     

    Participants may also rollover amounts representing distributions from other qualified defined benefit or defined contribution plans.

     

    Investment Options

     

    Participants direct investment of their contributions and the Companies’ contributions into the various investment options offered by the Plan. The Plan offers investments in The Clorox Company’s common stock, mutual funds, common collective trust funds and a money market fund.

     

    Participant Accounts

     

    Each participant’s account is credited with the participant’s contribution and an allocation of: (a) Company contributions and (b) Plan earnings. Allocations are based on participant’s eligible compensation for the employer match and employer non-elective contributions and investment balance for investment earnings. At the discretion of the Committee, forfeited balances of terminated participants’ non-vested accounts may be used to pay Plan expenses, to reduce the Companies’ contributions to the Plan, or to restore forfeited accounts of previously terminated participants who subsequently resumed employment with the Companies.

     

    6

     

    Vesting

     

    Participants are always fully vested in their individual contributions, the Companies’ matching contributions, and actual earnings thereon.

     

    The non-elective employer contributions account will vest in accordance with the following schedule:

     

    Schedule of non-elective employer contributions account vest   
    Years of Service  Percentage
    1  0%
    2  20%
    3  40%
    4  66%
    5  100%

     

    Participants become immediately vested in the non-elective employer contribution upon reaching age 60 while employed by the Companies, at death, or upon termination of employment due to permanent disability.

     

    Payment of Benefits

     

    The Plan provides for lump-sum distributions of the vested value of a participant’s account upon death, permanent disability, or termination of employment. The Plan also provides for installment distributions in limited instances. Hardship withdrawals are permitted if certain criterion are met.

     

    Notes Receivable from Participants

     

    Participants may obtain up to two loans for a minimum of $1,000 each and a maximum amount equal to the lesser of $50,000 reduced by the highest outstanding loan balance in the previous 12 months, or 50% of the participant’s vested account balance. Loan terms range from 1 to 5 years, or up to 15 years if the proceeds are used for the purchase of a primary residence. The loans are secured by the balance of the participant’s account and bear interest at a fixed rate (prime plus 1%) determined at the time of the loan. Principal and accrued interest is repaid ratably through payroll deductions.

     

    Plan Termination

     

    Although it has not expressed any intent to do so, the Companies have the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of a Plan termination, participants will become 100% vested in their accounts.

     

    7

     

    Administrative Expenses

     

    The Company pays all administrative expenses except for the quarterly recordkeeping fees, certain investment fees and loan fees, which are deducted from the affected participant’s account.

     

    Forfeitures

     

    The unallocated forfeitures related to non-vested accounts at December 31, 2025 and 2024 are $6,146 and $11,549, respectively. Subsequent to year end, the Companies used $11,200 and $11,000 of forfeitures to reduce the Companies’ non-elective employer contributions for the Plan years ended December 31, 2025 and 2024, respectively.

     

    2. Summary of Significant Accounting Policies

     

    Basis of Accounting

     

    The accompanying financial statements are prepared on the accrual basis of accounting in accordance with Accounting Principles Generally Accepted in the United States of America (U.S. GAAP”).

     

    The Plan’s financial statements were evaluated for subsequent events from the date after the financial statement date through June 25, 2026, the date the financial statements were issued.

     

    Investment Valuation and Income Recognition

     

    The Plan’s investments are stated at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 5 for further discussion of fair value measurements.

     

    Purchases and sales of securities are recognized on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. The net appreciation in fair value of investments consists of both the realized gains and losses and unrealized appreciation and depreciation of those investments.

     

    Benefit Payments to Participants

     

    Benefit payments to participants are recognized upon payment.

     

    Use of Estimates

     

    The preparation of financial statements in conformity with U.S. GAAP requires the Plan’s management to make estimates that affect the amounts reported in the financial statements and accompanying footnotes. Actual results could differ from those estimates.

     

    8

     

    Notes Receivable from Participants

     

    Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Interest income is recorded on the accrual basis. Delinquent participant loans are reclassified as distributions based upon the terms of the Plan Document.

     

    Risk and Uncertainties

     

    The Plan provides for various investment options in common stock, mutual funds, common collective trust funds and a money market fund. Investment securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risk. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities could occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, the statement of changes in net assets available for benefits and participant account balances.

     

    3. Party-in-Interest Transactions

     

    Certain Plan assets are in investment funds managed by the custodian of the Plan’s assets; therefore, these transactions qualify as party-in-interest transactions under the provisions of ERISA for which a statutory exemption exists.

     

    In addition, a portion of the Plan’s assets are participant directed investments in The Clorox Company common stock. As the Companies are subsidiaries of The Clorox Company, the Plan transactions involving The Clorox Company common stock qualify as party-in-interest transactions. During the Plan year ended December 31, 2025, the Plan purchased or received approximately $6,918 and sold or distributed approximately $11.322 of the Company’s common stock.

     

    4. Income Tax Status

     

    The Plan has received a determination letter from the Puerto Rico Treasury Department dated May 3, 2013, stating that the Plan meets the requirements of section 1081.01 (d) of the Code and that the trust established thereunder will be entitled to exemption from local income taxes. Subsequent to this determination by the Puerto Rico Treasury Department, the Plan was amended. The Plan’s management believes the Plan is being operated in compliance with applicable requirements of the Code and, therefore, believes that the Plan, as amended and restated, is qualified and the related trust is tax-exempt.

     

    U.S. GAAP requires Plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position meets certain recognition thresholds or measurement standards defined by U.S. GAAP. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that, as of December 31, 2025, there are no uncertain positions taken or expected to be taken. The Plan recognized no interest or penalties related to uncertain tax positions. The Plan may be subjected to routine audits by the taxing jurisdictions; however, there are currently no audits in progress for any tax periods.

     

    9

     

    5. Fair Value Measurements

     

    Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., an exit price). Fair value is determined based on a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. An asset or liability’s classification is based on the lowest level of input that is significant to the fair value measurement.

     

    Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

     

    Level 1 –Quoted market prices in active markets for identical assets or liabilities.

     

    Level 2 –Observable market-based inputs or unobservable inputs that are corroborated by market data.

     

    Level 3 –Unobservable inputs reflecting management’s own assumptions

     

    The following is a description of the valuation methodologies used for assets and liabilities measured at fair value:

     

    Mutual funds: Valued at quoted market prices of shares held by the Plan at year-end.

     

    Company’s common stock: Valued at the last reported sales price on the last business day of the Plan year.

     

    Common collective trust funds: Valued using the market approach at a net asset value per share (“NAV” as a practical expedient) determined by the portfolio’s sponsor based on the fair value of underlying investments held by the fund on the last business day of the Plan year. These are not classified in the fair value hierarchy table. The fair values are included in the table to allow reconciliation of the fair value hierarchy to the fair value of investments per the statements of net assets available for benefits.

     

    The stable value common collective trust fund measured at net asset value may impose, in its sole discretion, a prior notice period of up to 12 months for any plan initiated withdrawal of assets. Certain funds may also require that within 90 days from withdrawal, money from the funds cannot be invested directly into a competing fund. Certain funds retain the right to reject transactions where market timing activity is detected. Rejection can occur within 90 days, or for multiple infractions, rejection can be temporary or permanent. Generally, completing two ‘round trips’ within 60 days is considered market timing. A round trip consists of purchase or exchange if followed by or preceded by redemption or exchange out. Others retain discretion to limit the maximum withdrawal as of any date to the greater of $2,000,000 or 5% of the value of the investment.

     

    10

     

    The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

     

    The following table sets forth by level, within the fair value hierarchy, the Plan’s assets at fair value as of December 31, 2025 and 2024:

     

    Schedule of fair value hierarchy, the Plan's assets carried at fair value                        
       Assets at Fair Value as of December 31, 2025 
       Level I   Level II   Total 
    Mutual funds  $12,078,704   $-   $12,078,704 
    Company’s common stock   507,925    -    507,925 
    Total assets in the fair value hierarchy   12,586,629    -    12,586,629 
    Common collective trust funds measured at NAV, practical expedient             9,604,165 
    Investments at fair value            $22,190,794 
                    
        Assets at Fair Value as of December 31, 2024 
       Level I   Level II   Total 
    Mutual funds  $11,007,824   $           -   $11,007,824 
    Company’s common stock   790,547    -    790,547 
    Total assets in the fair value hierarchy   11,798,371    -    11,798,371 
    Common collective trust funds measured at NAV, practical expedient             8,895,806 
    Investments at fair value            $20,694,177 

     

    11

     

    Supplemental Information

    12

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

    EIN: 31-0595760 – Plan Number: 007

    Schedule H, Line 4(i) - Schedule of Assets (Held at End of Year)

    December 31, 2025

     

       (b) Identity of issue,
    (a) Borrower, Lessor, or Similar Party
      (c) Description
    of Investment
      (e) Current value 
               
    *  Vanguard Total International Stock Market Index Fund  Mutual fund  $1,521,522 
       Eaton Vance Atlanta Capital SMID Cap Fund  Mutual fund   779,662 
       Northern World Selection Index Fund  Mutual fund   78,771 
    *  Vanguard Target Retirement 2025 Fund  Mutual fund   914,233 
    *  Vanguard Target Retirement 2030 Fund  Mutual fund   332,197 
    *  Vanguard Target Retirement 2035 Fund  Mutual fund   4,202,512 
    *  Vanguard Target Retirement 2040 Fund  Mutual fund   411,880 
    *  Vanguard Target Retirement 2045 Fund  Mutual fund   3,315,649 
    *  Vanguard Target Retirement 2050 Fund  Mutual fund   306,968 
    *  Vanguard Target Retirement 2055 Fund  Mutual fund   60,209 
    *  Vanguard Target Retirement 2060 Fund  Mutual fund   4,020 
    *  Vanguard Target Retirement 2065 Fund  Mutual fund   5,607 
    *  Vanguard Target Retirement Inc Fund  Mutual fund   145,474 
                
              12,078,704 
                
    *  Vanguard Institutional 500 Index Trust  Common collective trust fund   4,219,966 
    *  Vanguard Institutional Total Bond Market Index Trust  Common collective trust fund   1,683,259 
       State Street Small Mid Cap Trust  Common collective trust fund   1,412,875 
       J.P. Morgan Chase Bank US Active Core Equity Fund  Common collective trust fund   1,135,454 
       Galliard Stable Return Fund  Common collective trust fund   600,882 
       MFS International Equity Fund  Common collective trust fund   327,950 
       Prudential Global Invesment Management Core Plus Bond Fund  Common collective trust fund   223,779 
              9,604,165 
                
    *  The Clorox Company Common Stock  Common stock   507,925 
                
    *  Participant Loans  Interest rates ranging from 4.25% to 9.50% and with maturities through September 2055   499,367 
                
       Total investments     $22,690,161 
    *Represents a party-in-interest to the Plan

    Note: Column (d) Cost is not presented as all investments are participant directed

     

    13

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      THE CLOROX COMPANY
      EMPLOYEE RETIREMENT INVESTMENT PLAN
    FOR PUERTO RICO
       
    Date: June 25, 2026 /s/ Angela Hilt
      Angela Hilt
      Executive Vice President – Chief Legal and
      External Affairs Officer and Corporate Secretary

     

     

     

    Index to Exhibits

     

    Exhibit No. Description
       
    23.1 Consent of Baker Tilly US, LLP

     

     

     

    Get the next $CLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLX

    DatePrice TargetRatingAnalyst
    4/17/2026$99.00Neutral → Underweight
    Analyst
    2/11/2026Underperform → Neutral
    BNP Paribas Exane
    10/1/2025$118.00 → $112.00Underweight
    Barclays
    1/7/2025$157.00Underweight → Equal Weight
    Wells Fargo
    11/6/2024$155.00 → $170.00Sell → Hold
    TD Cowen
    10/1/2024$174.00 → $187.00Hold → Buy
    Jefferies
    7/23/2024$122.00Sell
    TD Cowen
    6/24/2024$130.00Underperform
    Exane BNP Paribas
    More analyst ratings

    $CLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clorox Announces Simplified Operating Structure to Improve Execution and Accelerate Growth

    OAKLAND, Calif., June 17, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the company's strongest growth opportunities, advance portfolio optimization efforts and support faster execution across the enterprise to improve business performance.As part of the new structure, Chris Hyder, executive vice president and group president – Health & Hygiene (Health & Wellness and International reportable segments), has been appointed executive vice president and chief operating officer, effective immediately. In this expanded role, which consolidates leadership of all business units

    6/17/26 4:15:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges

    Clorox Healthcare launches two new innovative products designed to help close a critical compliance gap in daily disinfection: Clorox Healthcare Quat Alcohol Disinfecting Wipes, featuring a 1-minute contact time and 40% less alcohol*, and Clorox Healthcare HyperOxi Disinfecting Wipes a bleach-free sporicidal wipe powered by Quanticare Technology that is easy to use and gentle on surfaces.Clorox Healthcare unveils an expanded healthcare portfolio designed to advance infection prevention with a quat alcohol-based daily disinfecting wipe and a bleach-free sporicidal disinfecting wipe.Wipes innovations help address emerging pathogen threats, burdens and support compliance in fast-paced healthcar

    6/2/26 9:00:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Board of Directors to Initiate Comprehensive CEO Search Process

    Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced that Chair and Chief Executive Officer Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle will remain Chair and CEO while the search is conducted and until the new CEO is appointed. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition. The search will be comprehensive, led by an independent CEO search committee of the Board with the support

    5/28/26 4:05:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Clorox downgraded by Analyst with a new price target

    Analyst downgraded Clorox from Neutral to Underweight and set a new price target of $99.00

    4/17/26 8:07:27 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Clorox from Underperform to Neutral

    2/11/26 8:53:35 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Barclays reiterated coverage on Clorox with a new price target

    Barclays reiterated coverage of Clorox with a rating of Underweight and set a new price target of $112.00 from $118.00 previously

    10/1/25 10:49:28 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Breber Pierre R bought $429,124 worth of shares (5,000 units at $85.82) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    5/5/26 4:54:06 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Director Breber Pierre R bought $416,516 worth of shares (4,000 units at $104.13) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    11/24/25 4:37:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    5/9/25 4:25:25 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    SEC Filings

    View All

    SEC Form 11-K filed by Clorox Company

    11-K - CLOROX CO /DE/ (0000021076) (Filer)

    6/25/26 4:16:17 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 11-K filed by Clorox Company

    11-K - CLOROX CO /DE/ (0000021076) (Filer)

    6/25/26 4:15:35 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CLOROX CO /DE/ (0000021076) (Filer)

    6/17/26 4:15:35 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP - Chief Legal Officer Hilt Angela C was granted 26,324 shares, increasing direct ownership by 88% to 56,111 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    6/22/26 4:19:51 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    EVP - Chief Financial Officer Bellet Luc was granted 42,118 shares, increasing direct ownership by 204% to 62,756 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    6/22/26 4:19:52 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    EVP - Chief Admin Officer Marriner Kirsten was granted 26,324 shares, increasing direct ownership by 69% to 64,294 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    6/22/26 4:19:50 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Leadership Updates

    Live Leadership Updates

    View All

    Clorox Board of Directors to Initiate Comprehensive CEO Search Process

    Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced that Chair and Chief Executive Officer Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle will remain Chair and CEO while the search is conducted and until the new CEO is appointed. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition. The search will be comprehensive, led by an independent CEO search committee of the Board with the support

    5/28/26 4:05:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Coty Revamps Board With Appointment of Five New Independent Directors

    Highly Accomplished Global Leaders Strengthen Board with Deep Beauty, Brand-Building and Financial Expertise to Advance Coty's Strategic Evolution Regulatory News: Coty Inc. (NYSE:COTY) (PARIS:COTY) ("Coty" or "the Company") today announced that its Board of Directors (the "Board") has appointed five new independent directors as part of a comprehensive Board refreshment. The new directors are Carsten Fischer, Alia Gogi, Robert Kunze-Concewitz, Maria Carla Liuni, and Stephanie Plaines. Mr. Kunze-Concewitz will serve as Chair of the Board's Remuneration Committee and Ms. Plaines will serve as Chair of the Board's Audit and Finance Committee. Mr. Fischer has also been named as the Board's

    3/18/26 4:30:00 PM ET
    $CLX
    $COTY
    $JLL
    Specialty Chemicals
    Consumer Discretionary
    Package Goods/Cosmetics
    Real Estate

    Clorox Announces Appointment of Julia Denman and Stephanie Plaines to its Board of Directors

    OAKLAND, Calif., May 18, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the appointment of Julia (Charter) Denman and Stephanie Plaines to its board of directors, bringing additional deep financial expertise and industry leadership experience. Denman, 51, brings nearly 30 years of leadership and financial experience in both the technology and consumer packaged goods sectors. As corporate vice president and head of internal audit, enterprise risk and compliance at Microsoft, she provides independent and objective assessments of the company's business strateg

    5/18/22 4:30:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Financials

    Live finance-specific insights

    View All

    Clorox Reports Q3 Fiscal Year 2026 Results, Updates Outlook

    OAKLAND, Calif., April 30, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2026, which ended March 31, 2026.Third-Quarter Fiscal Year 2026 SummaryFollowing is a summary of key results for the third quarter. All comparisons are with the third quarter of fiscal year 2025 unless otherwise stated.Net sales of $1.67 billion were flat versus the year-ago quarter. Organic sales1 decreased 1%.Gross margin decreased 140 basis points to 43.2% from 44.6% in the year-ago quarter, primarily driven by higher manufacturing and logistics costs and unfavorable mix, partially offset by cost savings.Diluted net earnings per share (diluted EPS) incr

    4/30/26 4:10:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Completes Acquisition of GOJO Industries, Makers of Purell®

    Combination brings together two trusted, purpose-driven brands to advance health, hygiene and well-being of consumers and institutional end users alikeOAKLAND, Calif., April 1, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the completion of its previously announced acquisition of GOJO Industries, expanding Clorox's product portfolio to include the Purell® brand and GOJO's health and hygiene solutions. The combination brings together two companies with a shared commitment to making the world cleaner and healthier, leveraging complementary consumer brand-building expertise and B2B capabilities to deliver a more comprehensive product offering and both near- and long-term st

    4/1/26 8:00:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Declares Regular Quarterly Dividend of $1.24 Per Share

    OAKLAND, Calif., Feb. 24, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock. The dividend is payable May 8, 2026, to shareholders of record as of the close of business on April 22, 2026.Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases.About The Clorox CompanyThe Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation

    2/24/26 8:06:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/13/24 5:02:29 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/23 11:15:26 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/22 3:43:30 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary